Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Quick Stats
Jan 30, 202650.9
AI Score
HOLD0.45
Volume Ratio
Feb 26, 2026
Next Earnings
13
+ve Days (30d)
14
-ve Days (30d)
HRTX Stock Summary
Last updated Jan 30, 2026
HRTX is currently trading at $1.32, positioned below its 200-day moving average of $1.57, suggesting bearish momentum. The stock has a 52-week range of $0.9999 to $2.68.
Technical Analysis: The 50-day moving average stands at $1.3, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 44.64, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.114, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates HRTX at 50.9/100 with a HOLD recommendation.
HRTX (Heron Therapeutics, Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 44.64 |
| CMF (20) | -0.114 |
| ROC (10) | -11.409 |
| ADX (14) | 22.707 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.017 |
| AROONOSC (14) | |
| WILLAMS %R (14) | -96.154 |
| MFI (14) | 50.537 |
HRTX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
HRTX Price vs Max Options Open Interest
HRTX Max Change In Options Open Interest
HRTX Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
HRTX Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
HRTX Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
HRTX Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Heron Therapeutics, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
HRTX Moving Averages Analysis
Heron Therapeutics, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
HRTX (Heron Therapeutics, Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 1.41 |
| 20 | 1.38 |
| 30 | 1.36 |
| 50 | 1.3 |
| 100 | 1.27 |
| 200 | 1.57 |
HRTX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 242.0 million |
| Earnings/Share ($) | -0.09 |
| Net Proft Margin (%) | -0.0876 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.05 |
| EPS Estimate Next Year ($) | -0.05 |
| WallStreet Target Price ($) | 4.5 |
| Most Recent Quarter |